Back
Biogen Vs. Neurogene Industry Stock Comparison
Sell
42
BIIB
Biogen
Last Price:
$152.00
Seasonality Move:
3.03%
Sell
14
NGNE
Neurogene
Last Price:
$23.30
Seasonality Move:
23.27%
Sell
42
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
NGNE Stock Price Chart
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.78 | Sell |
Relative Strength Index (14 RSI): | 44.46 | Sell |
Chaikin Money Flow: | 1048703 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (149.29 - 159.51) | Sell |
Bollinger Bands (100): | (160.7 - 199.9) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 42.31 | Sell |
Chaikin Money Flow: | 174587 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.05 - 24.65) | Sell |
Bollinger Bands (100): | (24.72 - 49.58) | Sell |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 149.57 | Buy |
20-day SMA: | 152.95 | Sell |
50-day SMA: | 163.29 | Sell |
200-day SMA: | 199.3 | Sell |
8-day EMA: | 150.76 | Buy |
20-day EMA: | 153.17 | Sell |
50-day EMA: | 162.97 | Sell |
200-day EMA: | 195.38 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.76 | Buy |
20-day SMA: | 22.94 | Sell |
50-day SMA: | 34.03 | Sell |
200-day SMA: | 37.48 | Sell |
8-day EMA: | 22.88 | Sell |
20-day EMA: | 24.22 | Sell |
50-day EMA: | 30.14 | Sell |
200-day EMA: | 34.31 | Sell |
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $1.03 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.
Biogen Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |